Chronic lymphocytic leukemia, or chronic lymphocytic leukemia, is a disease in which some patients can survive for a long time or even be cured by hematopoietic stem cell transplantation, but the majority of patients do not need to receive hematopoietic stem cell transplantation in the first line.
Chronic lymphocytic leukemia is a slow-progressing, mature B-lymphocyte proliferative neoplasm, the cause and pathogenesis of which have not yet been clarified. Not all patients require immediate treatment upon diagnosis, and it is currently believed that early-stage patients do not require treatment and regular follow-up is sufficient. Patients with active disease are advised to start treatment.
Chronic lymphocytic leukemia is a highly heterogeneous disease. About 10% of patients have a rapid progression of the disease, making it easy to miss the optimal time for treatment, while some patients may have decades or more of disease-free progression.
Common treatments for chronic lymphocytic leukemia include chemotherapy, immunotherapy, chemoimmunotherapy, molecular targeted therapy, and hematopoietic stem cell transplantation. In addition, patients should be actively treated and prevented from infections.
When diagnosed with chronic lymphocytic leukemia, it is recommended to do standardized treatment under the guidance of a doctor.